|
|
View Clinical Trial (Medical Research Study)
|
Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal Women - NCT00470119-98109 (Clinical Trial 169496)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy169496.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Seattle |
|
State:
|
|
WA |
| Zip Code: |
|
98109 |
| Conditions: |
|
Breast Cancer - Obesity - Weight Changes |
| Purpose: |
|
RATIONALE: A low-calorie diet and/or exercise program may help lower an overweight or obese
postmenopausal woman's risk of developing breast cancer. It is not yet known whether a
low-calorie diet and/or exercise program are more effective than no diet or exercise program
in lowering an overweight or obese postmenopausal woman's risk of developing breast cancer.
PURPOSE: This randomized clinical trial is studying the effect of a low-calorie diet and/or
exercise program on risk factors for developing breast cancer compared with no diet or
exercise program in overweight or obese postmenopausal women.
|
| Study summary: |
|
OBJECTIVES:
Primary
- Compare the effects of a 1-year exercise intervention, reduced-calorie diet
intervention, or a combined exercise and reduced-calorie diet intervention vs no
intervention on serum estrone concentrations in overweight or obese postmenopausal
women.
Secondary
- Compare the effects of these interventions on serum estradiol and free estradiol in
these participants.
- Compare the effects of these interventions on serum testosterone and free testosterone
in these participants.
- Compare the effects of these interventions on sex hormone binding globulin in these
participants.
- Compare the effects of these interventions on insulin in these participants.
- Compare the effects of these interventions on insulin-like growth factor (IGF)-1 and
IGF binding protein-3 in these participants.
- Compare the effects of these interventions on mammographic density in these
participants.
- Compare the effects of these interventions on anthropometrics and body composition
(i.e., weight, body mass index, total and percentage body fat, and waist and hip
circumferences) in these participants.
- Compare the effects of these interventions on quality of life in these participants.
OUTLINE: This is a randomized study. Participants are stratified according to body mass
index (< 27 vs ≥ 27). Participants are randomized to 1 of 4 intervention arms.
- Arm I (exercise program): Participants exercise 3 days per week under the supervision
of a physiologist and 2 days per week independently at home, for a total of 5 exercise
sessions (at least 45 minutes of moderate-intensity exercise per session) weekly over
12 months.
- Arm II (reduced-calorie diet): Participants meet with a nutritionist individually and
in small groups. Participants receive general information about diet and behavior
strategies such as self-monitoring, goal-setting, stimulus-control, problem-solving,
and relapse-prevention training. Participants learn to set a calorie goal and a fat
gram goal and how to achieve the goal calorie reduction. Meetings are held weekly
during the first 6 months of the diet program but taper off over the course of the
study.
- Arm III (exercise program and reduced-calorie diet): Participants meet with a
physiologist and a nutritionist, as in arms I and II, and exercise and diet
accordingly.
- Arm IV (control: delayed diet and exercise): Participants receive study materials on
healthy diet and exercise at the end of the 12-month study period. In addition,
participants are offered 2 months of group exercise training with a study physiologist
and 4 group meetings with a nutritionist to learn about weight loss techniques and
behavioral principles for achieving weight loss.
All participants undergo testing at baseline and periodically during study. Participants
undergo blood collection for evaluation of serum levels of sex and metabolic hormones (i.e.,
estrone, estradiol, testosterone, free testosterone, sex hormone binding globulin, insulin,
insulin-like growth factor [IGF]-1, and IGF binding protein-3) by radioimmunoassay and other
immunoassays. Participants also undergo anthropometrics and body composition measurements
and mammographic density assessment.
Participants complete questionnaires at baseline and at 6 and 12 months for assessment of
diet and exercise. Quality of life (QOL) is measured at baseline and at 6 and 12 months
using the Medical Outcomes Study 36-Item Short Form and the Impact of Weight on QOL
questionnaire. Information on health habits, medical history, family history of breast
cancer, and reproductive and menstrual history is also collected.
PROJECTED ACCRUAL: A total of 503 participants (135 per intervention arm and 98 in control
arm) will be accrued for this study. |
| Criteria: |
|
DISEASE CHARACTERISTICS:
- At increased risk for developing breast cancer due to any of the following lifestyle
risk factors:
- Lack of physical activity
- Excess weight
- Obesity
- Weight gain over lifetime
- Body mass index > 25.0
- Physically able to undertake a moderate exercise or calorie reduction program
- No history of invasive or in situ breast cancer
PATIENT CHARACTERISTICS:
- Postmenopausal, defined by the absence of periods for the past 12 months
- Able to attend study clinic visits and classes, and undergo study measurements
- Able to fill out questionnaires and logs in English
- No moderate to high alcohol intake (more than 2 drinks per day)
- No concurrent smoking
- No invasive cancer within the past 10 years except simple basal cell or squamous cell
carcinoma
- No diabetes mellitus
- Fasting blood sugar < 126 mg/dL (on 2 occasions)
- Hematocrit 32-48%
- WBC 3,000-15,000/mm³
- Potassium 3.5-5.0 mEq/L
- Creatinine ≤ 2.0 mg/dL
- No abnormalities on screening physical that contraindicate study participation
- No contraindications for treadmill testing or entry into a training program,
including any of the following:
- Myocardial infarction within the past 6 months
- Pulmonary edema
- Myocarditis
- Pericarditis
- Unstable angina
- Pulmonary embolism or deep vein thrombosis
- Uncontrolled hypertension (i.e., blood pressure > 200/100 mm Hg)
- Orthostatic hypotension
- Moderate-to-severe aortic stenosis
- Uncontrolled arrhythmia
- Uncontrolled congestive heart failure
- Third-degree heart block
- Left bundle branch block
- Thrombophlebitis
- ST depression > 3 mm at rest
- History of cardiac arrest or stroke
- Normal exercise treadmill testing (ETT)
- Negative thallium or echo ETT required for patients with abnormal ETT (defined
as ≥ 1.5 mm ST depression in > 1 lead within 1-minute recovery OR ≥ 1.1 mm ST
depression in > 1 lead after 1-minute recovery OR reading of positive test by
study doctor)
- No drug abuse
- No significant mental illness
PRIOR CONCURRENT THERAPY:
- More than 6 months since prior and no concurrent menopausal hormone replacement
therapy of any type, including vaginal route
- No concurrent participation in any other organized weight loss or exercise program
- No concurrent appetite suppressant medication
- No concurrent medications (e.g., weight-loss medications) likely to interfere with
adherence to interventions or study outcomes |
|
|
|
| Study is available at: |
|
Fred Hutchinson Cancer Research Center
Seattle, WA 98109
United States
Primary Contact:
Contact Person
Email: new@fhcrc.org
Phone: 206-667-6444 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 16, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|
|
|
|